NBI-1117570: Clinical Trials

1 trial of NBI-1117570, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow NBI-1117570: new trials by email Literature Review of NBI-1117570 trials Research Report on NBI-1117570

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
NBI-1117570, Placebo - Schizophrenia
Phase 2RecruitingNeurocrine Biosciences1202026-02-162026-07-22

Conditions studied

Schizophrenia (1)

Sponsors

Neurocrine Biosciences (1)

Countries

Bulgaria (1)  ·  Romania (1)  ·  United Kingdom (1)

NIH funding

2025 (1)